is all in $AAPL $TSLA and $PMCB
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New York City Private Equity Firm Brings Cannabis Investing to Institutional Investors
https://www.newcannabisventures.com/new-york-city-private-equity-firm-brings-cannabis-investing-to-institutional-investors/
New York City Private Equity Firm Brings Cannabis Investing to Institutional Investors
A must watch interview with Tress Capital co founder
https://www.newcannabisventures.com/new-york-city-private-equity-firm-brings-cannabis-investing-to-institutional-investors/
Well, if G*PH gets it's way only FDA approved cannabinoids will be legal in some MMJ States. https://www.leafly.com/news/politics/leafly-exclusive-gw-pharma-moving-cbd-bills-low
With IRB approval pending and FDA Phase 1 ending in July, I think OWCP is in a good position.
IF I had psoriasis I would absolutely be trying any and every remedy, but I think a person holding an IRB approved cream in one hand and a generic "CBD balm" in the other hand will have a very easy choice to make at checkout.
The terms of the two contacts they signed were to split profits 75% to OWCP and 25% to the manufacturer if I'm remembering correctly.
Let it go. Don't let stuff like that haunt you. You made the best decision at the time. Don't beat yourself up. Hindsight is 20/20 as they say.
I don't like to be stressed about my biotech stocks, so my ideal trading plan for stocks like $OWCP goes something like this (using nice round numbers for easy math):
Buy 1,000 @ $10.00 = $10,000
Sell 100 @ $11; Sell 100 @ $11.50; Sell 100 @ $12; Sell 100 @ $12.50 and Sell 100 @ $13 = $6,000.
Now I essentially have 500 for $4,000 or 500 shares @ $8. I won't be so stressed about my 500 shares during swings. I have a very comfortable cushion and, if the stock drops to $9, I might even be a buyer again.
I traded all the Canadian LP MJ stocks this way and it was very low stress.
All depends of course. OWCP has a lot of moving parts to keep track of. Generally speaking, you have to know what the company is doing and watch for News and employ Alerts.
Always good to have a plan with contingencies too. I will admit that this trading strategy has left a lot of money on the table, however. It is painful to calculate sometimes so I try not to think about it. : (
For example, I've been trading Z*NE this way and I just have a bit left now and, surprise, it got new coverage with a higher price target. Doh!
My exact thoughts on PPS. Nice to see others coming to the same conclusions.
Thank you very much! I've book marked https://pcaobus.org. Member mark for you.
3 separate studies. 2 in Israel under IRB, 1 starting soon for FDA Phase 1.
https://clinicaltrials.gov/ct2/show/NCT02976779?term=one+world+cannabis&rank=1
You missed the boat on the Wall play IMHO. Bought $URI and $X in November and they have done very well as "Wall" stocks. Anyone who isn't following Trump on Twitter today shouldn't be investing IMHO.
I think MMJ has legs, but you're right because it is a high risky investment. It could all come crashing down with a single tweet from Trump.
But ETF Fund Managers seem to have their finger on what's trendy and they are clearly saying MMJ is the next "flavor of the month". http://nypost.com/2017/02/17/medical-marijuana-has-gone-corporate/
Will the MMJ ETF be the next $HACK or the next $WSKY?
Sector Rotation into MMJ by aggressive and risk-tolerant investors is happening now IMHO.
Big Pharm likely won't step in until cannabis is removed from DEA's Schedule 1. Good thing the bipartisan "cannabis caucus" has 14 cosponsors in the US Congress. https://blumenauer.house.gov/cannabis-caucus. Good old Earl couldn't stop himself from criticizing Trump recently, so who knows where this will go.
But this interview caught my eye as it reenforces my observation that money is pouring into MMJ:
CannaRoyalty Races to Invest in the Cannabis Industry Before Big Investors Arrive
https://www.newcannabisventures.com/cannaroyalty-races-to-invest-in-the-cannabis-industry-before-big-investors-arrive/
I lost almost $50K on WorldCom years ago, scams come in every size, shape and form. But thank goodness the blatant ones are so easy to spot because of the shoddy webpages.
After MJ/MMJ became legal in 25 States last November, I decided I would invest in MJ/MMJ stocks. Traded the Canadian LPs for a bit, then decided to take profits into MMJ. Problem is, there are only a three. GWPH of course, then ZYNE and CARA. The rest of the MMJ companies are ALL OTC stocks.
Anyway, thanks for the tips. Member mark for ya.
P&D and now D&P lol Sounds like best advice is to just stay away from all penny stocks.
Yeah, I get tips all the time and it takes me about 10 seconds to decide not to buy shares for .0001 where there are 50 billion shares outstanding and "exciting news coming soon".
Since I joined this website the Hot! Breakout Boards have been exclusively OTC.
Is there any way globally to filter out by exchange? Can Admins add Hot! NYSE and Hot! NASDAQ?
OWCP is the very first OTC stock that I've ever purchased. All my finance friends said to stay away, so that's actually how I found this website, lol
Anyway, I want to do more DD now that you have me worrying. Can you tell me the tickers of some recent OTC P&Ds? Want to start looking for similarities and compare charts.
Thanks in advance!
I hear ya. I've put in several 100K orders at .105 that haven't been filled. : (
Sure which I knew about this gem earlier!
Just going to leave this article here. It's from 2015. Interview with Dr. Alan Shackelford, widely known as the doctor from "Charlotte's Web" and Dr. Gupta's video series on MMJ:
I've read repeatedly in late 2016 that $XLNX was an ideal takeover target. Thoughts?
"front loading by Renee in early October". Do you mean when OWCP's former law firm dropped the ball while negotiating the price of new shares and allowed the broker-dealer to just dump all the shares, driving the price down from .20 to .003? The former law firm that was delivered a demand letter and will very likely be sued since those 30 Million shares are worth a bit more than they were in Sept.
I don't know how OTC pump and dumps work, in all honesty, but getting "accredited investors", i.e., millionaires involved doesn't seem very smart. Isn't the goal to get stupid people to bag hold? And using Restricted Stock would be pretty stupid as well, since it's locked up and may have other conditions on the sale. Options that were issued at about half the trading price also seems like a silly strategy. Wouldn't they just issue unrestricted stock for pennies. Why bother with restricted shares and locked-up warrants?
The consensus on the OWCP board is that those placements were made for Dr. Rozenblat and Ms. Miriam Sani, two new advisors who have expertise in FDA filings, patent perfection, dermatology, and selling products in the EU and Asia.
The OWCP board has also confirmed via emails that the Insiders at the wholly-owned Israeli sub have their shares held in trust. In fact, the newish CEO hasn't even been granted his shares yet since he hasn't been at the company for two years, which is apparently the Israeli waiting period.
From what I've read the only people who would benefit from a P&D is the current shareholders. The Insiders have far too few shares.
As keynote sponsor, OWCP's name will be on the swag bags and featured in the first few pages of the conference handbook. Lots of good marketing for the whole event.
The people coming to this type of conference are from the Research side of funds. Not the trading side, unless it's a small fund where people do both.
I would be very surprised if these guys didn't do any DD. These are not events where funds go to learn about companies, this is where you go to ask specific questions after you've done a lot of DD.
Indeed, that would be a fantastic trigger!
Webcast recording of CEO Scott Wolchko on Feb 15, 2017 at the Leerink Partners 6th Annual Global Healthcare Conference
http://ir.fatetherapeutics.com/events.cfm
Pipeline for $FATE http://fatetherapeutics.com/our-immuno-pipeline/
The Barchart Technical Opinion rating for $FATE is a 96% Buy with a Average short term outlook on maintaining the current direction.
Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.
https://www.barchart.com/stocks/quotes/FATE
When a fund wants to buy into a stock they will first try to go to a dark pool to not tip anyone off. Doubt that OWCP is in any dark pools, but it's possible with all the shares that traded hands in Sept.
The normal way they buy, however, is to set a price target and buy the stock when it's in their price range. Very calmly. Funds aren't going to run up a stock they are trying to buy UNTIL they have all the shares they want.
140,000,000 shares outstanding is plenty of liquidity.
I've looked at OWCP's financials and I don't see any expenses for marketing. Any chance you still have a copy of the paid email campaign from Sept? I'd really love to see the disclaimer at the bottom. Thank you in advance!
OK, but only for pure entertainment:
OWCP: Monday: Open at $2 closing at $3.50
Friday Open at $6.50 closing at $7.07
Well, OWCP has been great for the momentum traders. IF you have a true share value in mind, you can buy and sell with confidence all day long.
I'm sure they don't post often, but they are making bank!!! From what I've seen over the last few weeks OWCP doesn't drop news during market hours, so that's gonna work in your favor.
In the latest 8-K we learned that $OWCP issued Restricted Stock to raise working capital in Jan and Feb.
That was a very smart, strategic move IMHO.
Talk about having to issue further shares to "attract Hedge Funds" is so far off base I don't know where to begin.
Generally speaking, issuing more shares is NOT helpful for current shareholders. Period.
Let's stick to the facts and not speculate about future dilution.
Go OWCP Longs!!!
I know, I think I missed the boat on that one. Best of luck trading it. I hope you make $$$$$$ my friend!!!
Ah, nope. Issuing shares is to raise capital. It actually drives share price down if not done correctly (like with Restricted Shares that we learned about on Friday).
CARA is another MMJ companies with just 27 M shares outstanding and over 50% institutional ownership.
You are absolutely right and I'm another Trader who has turned into an Investor with OWCP. Still have every single share I ever purchased.
While I have no plans to sell until 2018 for tax efficiency reasons, there could be triggers that cause me to release small portions. The only trigger I was expecting in the next few weeks was the safety and efficacy studies. Now it seems efficacy will come before safety. However, after Friday's 8-K showed $OWCP has gained $1,624,640 in new financing, we could have a bunch of new triggers.
$1.6M is a lot of money for our careful and thoughtful All-Star Team at OWCP. They could use those funds in many exciting ways. I wasn't expecting anything major until revenue from the psoriasis cream starts coming in Q2 and Q3. As Camelot says, "OWCP could easily drop more hammers!" now with all that new funding.
Will they start up new clinical trials for other indications for the topical cream? Will they start Phase I trials with the FDA for multiple myeloma, PTSD or Migraines?
News like that, which I wasn't expecting to hear about until Q3-Q4, could now come before Summer.
Such an exciting time to be an OWCP Investor!
Smart money going to that conference has already done preliminary DD on the sponsor companies. I'd be very surprised if people going hadn't already opened a small position in $OWCP. If they like what they see and hear, they will expand those positions.
It's not what OWCP is planning to present that is important at these events. It is the questions that potential investors ask that will truly drive things. People who drop a cool $1M want some face-to-face assurances.
So, Friday's 8-K was only about the SAFETY study. Remember, there is also an expanded EFFICACY study that is due "March 2017". OWCP could drop hints at the conference (while filing official news with the SEC, of course), because their appearance is around 3 p.m. and that is very close to market close. Nothing illegal of course, just a "we are anticipating releasing the results of our efficacy test any day now" would be enough IMHO.
Now there are people who attend these sorts of conferences who are very, very wealthy and there very well could be an uptick if they like what they see. Watch the tape on the 2nd and look for HUGE buy blocks.
On 2/7/17, Revive Therapeutics Announces Initiation of a Phase 2 Study of REV-004 (Bucillamine) in Cystinuria
Revive Therapeutics Announces Term Sheet With InMed Pharmaceuticals For The Discovery And Development Of Cannabinoid-Based Therapy Targeting Kidney Diseases
https://www.barchart.com/stocks/quotes/RVV.VN/news#/news/665363/revive-therapeutics-announces-term-sheet-with-inmed-pharmaceuticals-for-the-discovery-and-development-of-cannabinoid-based-therapy-targeting-kidney-diseases
Barchart for the Canadian ticker:
The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.
Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.
The market is approaching overbought territory. Be watchful of a trend reversal.
https://www.barchart.com/stocks/quotes/RVV.VN
The Barchart Technical Opinion rating for $OWCP is a 100% Buy with a Strongest short term outlook on maintaining the current direction.
Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.
https://www.barchart.com/stocks/quotes/OWCP
Last news was Feb 13:
Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine
http://ir.zosanopharma.com/releasedetail.cfm?ReleaseID=1011563